Potentially fatal severe brady arrythmias related to Lopinavir-Ritonavir in a COVID 19 patient

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Journal of Microbiology, Immunology and Infection
المؤلفون الرئيسيون:	Venkatesan Shree, Lydia Qi En Liew, Wei Wei Teo, Jeanette Ting, Mei Fong Liew
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2021-02-01
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S1684118220301717

مواد مشابهة

Recurrent oedema associated with the co-formulation of lopinavir and ritonavir Edema recorrente associado à co-formulação de lopinavir e ritonavir
حسب: Jorge Francisco C. Pinto, وآخرون
منشور في: (2004-08-01)

Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
حسب: Ana Pelufo-Pellicer, وآخرون
منشور في: (2017-03-01)

The effect of lopinavir - ritonavir on mortality in COVID-19 pneumonia
حسب: Muhammed Emin Demirkol, وآخرون
منشور في: (2024-10-01)

COVID-19 Hastalarında Lopinavir/Ritonavir ve Favipravir Deneyimi
حسب: Esma Eroğlu, وآخرون
منشور في: (2020-12-01)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
حسب: V. B. Denisenko,, وآخرون
منشور في: (2018-12-01)

Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?
حسب: Adewale Bayode Owa, وآخرون
منشور في: (2020-10-01)

HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
حسب: A. V. Sulebhavikar, وآخرون
منشور في: (2008-01-01)

Lopinavir/Ritonavir for COVID-19: a Systematic Review and Meta-Analysis
حسب: Bahman Amani, وآخرون
منشور في: (2021-05-01)

Correction: Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir).
حسب: Kathleen M. S. E. Reyskens, وآخرون
منشور في: (2013-01-01)

Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation
حسب: Wilhelm P. Greffrath, وآخرون
منشور في: (2018-06-01)

Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children
حسب: Beatriz Larru Martinez, وآخرون
منشور في: (2010-03-01)

Severe COVID-19 infection in a kidney transplant recipient treated with lopinavir/ritonavir, hydroxychloroquine and dexamethasone
حسب: Satriyo Dwi Suryantoro, وآخرون
منشور في: (2021-09-01)

Electrospun Amorphous Solid Dispersions with Lopinavir and Ritonavir for Improved Solubility and Dissolution Rate
حسب: Ewelina Łyszczarz, وآخرون
منشور في: (2024-09-01)

USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
حسب: Fernando Raphael de Almeida Ferry, وآخرون
منشور في: (2014-06-01)

Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment
حسب: Paola Magro, وآخرون
منشور في: (2021-03-01)

Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities
حسب: Mario Ferreira Peixoto, وآخرون

Lopinavir/ritonavir dosing during pregnancy in Brazil and maternal/infant laboratory abnormalities
حسب: Mario Ferreira Peixoto, M.D., وآخرون
منشور في: (2011-05-01)

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.
حسب: Nicola Gianotti, وآخرون
منشور في: (2017-01-01)

The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation
حسب: David W. Pittman, وآخرون
منشور في: (2018-01-01)

Acute Kidney Injury Associated With Lopinavir/Ritonavir Combined Therapy in Patients With COVID-19
حسب: Yannick Binois, وآخرون
منشور في: (2020-10-01)

Coadministration of lopinavir/ritonavir and rifampicin in HIV and tuberculosis co-infected adults in South Africa.
حسب: Richard A Murphy, وآخرون
منشور في: (2012-01-01)

Simultaneous determination of plasma lopinavir and ritonavir by chemometrics-assisted spectrophotometry and comparison with HPLC method
حسب: Chutima Matayatsuk Phechkrajang
منشور في: (2013-06-01)

Dyslipidaemia associated with the highly active antiretroviral therapy in aids patient: reversion after switching (stavudine to tenofovir and lopinavir/ritonavir to atazanavir/ritonavir)
حسب: Hamilton Domingos, وآخرون

The Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARSCoV- 2 Pneumonia
حسب: Ayşe BATIREL, وآخرون
منشور في: (2021-12-01)

Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis
حسب: Saad Alhumaid, وآخرون
منشور في: (2020-11-01)

Development of In Situ Self-Assembly Nanoparticles to Encapsulate Lopinavir and Ritonavir for Long-Acting Subcutaneous Injection
حسب: Irin Tanaudommongkon, وآخرون
منشور في: (2021-06-01)

Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial
حسب: Alexander M. Kaizer, وآخرون
منشور في: (2023-03-01)

A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections
حسب: Purwati, وآخرون
منشور في: (2021-01-01)

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
حسب: Yan-Ming Zeng, وآخرون
منشور في: (2020-05-01)

In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
حسب: Chang Kyung Kang, وآخرون
منشور في: (2020-07-01)

FOR VERONICA BRADY
حسب: Susan Ballyn
منشور في: (2016-11-01)

Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort
حسب: Dóra Paróczai, وآخرون
منشور في: (2025-01-01)

Cardiomyopathies and Arrythmias in Neuromuscular Diseases
حسب: Giuseppe Sgarito, وآخرون
منشور في: (2025-03-01)

Electrocardiography in the Supraventricular cardiac arrythmias
حسب: Claudia Liliana Sanabria Peña, وآخرون
منشور في: (1998-08-01)

Persistent hepatocyte secretory failure in lopinavir/ritonavir related to drug-induced liver injury: a case report
حسب: Yue Sun, وآخرون
منشور في: (2025-02-01)

Is the efficacy of remdesivir so different from that of lopinavir-ritonavir in severe COVID-19? The answer by real time-PCR: a narrative review
حسب: Tiago Isidoro Duarte, وآخرون
منشور في: (2021-07-01)

Influence of traditional Chinese medicines on the in vivo metabolism of lopinavir/ritonavir based on UHPLC-MS/MS analysis
حسب: Linlin Li, وآخرون
منشور في: (2022-04-01)

Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam.
حسب: Nguyen Thi Ngoc Lan, وآخرون
منشور في: (2014-01-01)

Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?
حسب: Hasan M. Shihab, وآخرون
منشور في: (2009-06-01)

What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed?
حسب: Yu. Yu. Kiselev, وآخرون
منشور في: (2020-10-01)